A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C

Hepatology

Volumn 23, Issue 5, 1996, Pages 953-957

  Chayama, Kazuaki ^a   Tsubota, Akihito ^a   Kobayashi, Masahiro ^a   Hashimoto, Michie ^a   Miyano, Yukiko ^a   Koike, Hiromi ^a   Kobayashi, Mariko ^a   Koida, Isao ^a   Arase, Yasuji ^a   Saitoh, Satoshi ^a   Murashima, Naoya ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CORTICOSTEROID; PREDNISOLONE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTHRALGIA; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; FATIGUE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUNGER; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; REBOUND; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP DISORDER; VIRUS HEPATITIS;

EID: 15844399125     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008621174     Document Type: Article

References (24)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
2. Kuo G, Choo QL, Alter HJ, Gitnick L, Redeker G, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362-364.
3. Esteban JI, Esteban R, Viladomiu L, Lopez-Alavera JC, Gonzalez A, Hernandez JM, Roget M, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1990;335:294-297.
4. Van der Poel CL, Reesink HW, Lelie PN, Leentcaar-Kuypers A, Choo QL, Kuo G, et al. Anti-hepatitis C antibodies and non-A, non-B posttransfusion hepatitis in the Netherlands. Lancet 1990;335:297-298.
5. Alter HJ, Purcell RH, Shin JW, Melpolder JC, Houghton M, Choo QL, Kuo G, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-1500.
6. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo QL, et al. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A 1990;87:983-987.
7. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983;85:439-462.
8. Koretz RL, Stone O, Mousa M, Gitnick GL. Non-A, non-B post-transfusion hepatitis - a decade later. Gastroenterology 1985; 88:1251-1254.
9. Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, et al. Effect of Interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. HEPATOLOGY 1991;13:1040-1043.
10. Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. HEPATOLOGY 1992;15:1013-1016.
11. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989;321: 1501-1506.
12. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 1989; 321:1506-1511.
13. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. A pilot study of Ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 1993;105: 507-512.
14. Cohard M, Poynard T, Philippe M, Zarski JP. Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis. HEPATOLOGY 1994;20:1390-1398.
15. Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A 1991;88: 10445-10449.
16. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Virol 1992; 149:3339-3344.
17. Liaw Y-F, Sheen I-S, Lin S-M, Chen T-J, Cu C-M. Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis. Liver 1993;13:46-50.
18. Chayama K, Tsubota A, Arase Y, Saitoh S, Ikeda K, Sakai Y, Matsumoto T, et al. Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reaction. J Gastroenterol Hepatol 1993;8:S40-S44.
19. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-238.
20. Urdea MS, Horn T, Fultz TJ, Anderson M, Running JA, Hamren S, Ahle D, et al. Branched chain DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Res 1991;24:197-200.
21. Chayama K, Tsubota A, Arase Y, Saitoh S, Koida I, Ikeda K, Matsumoto T, et al. Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol 1993;8:150-156.
22. Dixon WJ, Brown MB, Engleman L. BMDP statistical software. Berkeley: University of California Press, 1983.
23. Fong T-L, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994;107:196-199.
24. Tsubota A, Chayama K, Ikeda K, Arase Y, Koida I, Saitoh S, Hashimoto M, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. HEPATOLOGY 1994; 19:1088-1094.